Boyd Watterson Asset Management LLC Amgen Inc Transaction History

Boyd Watterson Asset Management LLC

$358 Million
Q3 2024

A detailed history of Boyd Watterson Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 983 shares of AMGN stock, worth $289,522. This represents 0.09% of its overall portfolio holdings.

Number of Shares

983

Previous 990 0.71%

Holding current value

$289,522

Previous $309,000 2.27%

% of portfolio

0.09%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $2,165 - $2,361	-7 Reduced 0.71%	983 $316,000
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $268 - $324	1 Added 0.1%	990 $281,000
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $1,278 - $1,442	-5 Reduced 0.5%	989 $284,000
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $437 - $542	-2 Reduced 0.2%	994 $267,000
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $642 - $760	3 Added 0.3%	996 $221,000
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $37,481 - $45,683	166 Added 20.07%	993 $240,000
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $14,886 - $18,915	-65 Reduced 7.29%	827 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $538,704 - $607,560	-2,400 Reduced 72.9%	892 $201,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $2,768 - $3,080	-12 Reduced 0.36%	3,292 $801,000
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $1,534 - $1,697	7 Added 0.21%	3,304 $799,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $4,574 - $5,234	-23 Reduced 0.69%	3,297 $742,000
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $636 - $746	-3 Reduced 0.09%	3,320 $706,000
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $3,737 - $4,146	16 Added 0.48%	3,323 $810,000
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $5,769 - $6,723	-26 Reduced 0.78%	3,307 $823,000
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $5,409 - $6,441	-25 Reduced 0.74%	3,333 $766,000
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $21,118 - $23,485	-90 Reduced 2.61%	3,358 $853,000
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $32,194 - $36,290	-178 Reduced 4.91%	3,448 $655,000
Q4 2018 Jan 16, 2019	SELL	$178.4 - $208.25 $7,136 - $8,330	-40 Reduced 1.09%	3,626 $706,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $38,910 - $43,866	-210 Reduced 5.42%	3,666 $760,000
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $346,878 - $389,619	-2,089 Reduced 35.02%	3,876 $715,000
Q1 2018 Apr 19, 2018	BUY	$169.43 - $198.0 $53,370 - $62,370	315 Added 5.58%	5,965 $1.02 Million
Q4 2017 Jan 11, 2018	BUY	$168.79 - $188.59 $225,165 - $251,579	1,334 Added 30.91%	5,650 $983,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $722,023 - $824,356	4,316	4,316 $805,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.

Account

Boyd Watterson Asset Management LLC Amgen Inc Transaction History